TABLE 2.
Profiles of COVID-19 vaccine-associated Top 10 AEs in females and males. Data is derived from VAERS case reports from all COVID-19 vaccines as of 31 December 2021.
| # | AE | # Of cases in females | % in total female cases | # Of cases in males | % in total male cases | F/M case ratio | F/M % ratio |
|---|---|---|---|---|---|---|---|
| 1 | Headache | 94,367 | 0.196 | 28,300 | 0.135 | 3.33 | 1.452 |
| 2 | Pyrexia | 74,910 | 0.156 | 28,802 | 0.137 | 2.6 | 1.139 |
| 3 | Fatigue | 77,049 | 0.16 | 25,447 | 0.121 | 3.03 | 1.322 |
| 4 | Chills | 66,146 | 0.137 | 23,066 | 0.11 | 2.87 | 1.245 |
| 5 | Pain | 67,849 | 0.141 | 20,731 | 0.099 | 3.27 | 1.424 |
| 6 | Dizziness | 51,097 | 0.106 | 19,553 | 0.093 | 2.61 | 1.14 |
| 7 | Nausea | 55,307 | 0.115 | 14,415 | 0.069 | 3.84 | 1.667 |
| 8 | Pain in extremity | 51,915 | 0.108 | 14,852 | 0.071 | 3.5 | 1.521 |
| 9 | Myalgia | 30,550 | 0.063 | 11,708 | 0.056 | 2.61 | 1.125 |
| 10 | Arthralgia | 30,126 | 0.063 | 11,350 | 0.054 | 2.65 | 1.167 |